Category: Health & Medicines > Medicines
Country/Region: China State/Province: Jiangsu
Main Products: Dapagliflozin Intermediate Sofosbuvir Intermediate DARUNAVIR INTERMEIDATE CITICOLINE INTERMEIDATE ACETAZOLAMIDE VALSARTAN INTERMEDIATE
Business Type: Wholesaler, Buying House
Year Established: 2003
Employees: 101 - 200 People
Plant Area: 50,000-100,000 square meters
Main Markets: South America 10% Africa 9% Eastern Asia 10% Domestic Market 11% North America 9% Eastern Europe 9% Southern Europe 11% Mid East 10% Northern Europe 8% Oceania 13%
Trade Capacity: FOB, EXW, DDP
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Nantong
Annual Revenue: Above US$100 Million
Total Revenue: US$5 Million - US$10 Million
Export Revenue: Above US$100 Million
Annual Output: US$5 Million - US$10 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 51% - 60%
Payment Modes: USD, JPY, CHF
Lead Time: 29 days
Import/Export Mode: LLC (Limited Liability Corp)